Literature DB >> 19741067

Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.

Kilian Weigand1, Andreas Knaust, Heinz Schaller.   

Abstract

Little is known about the parameters and factors that determine the intracellular distribution of the hepatitis B virus core protein (HBc). In order to study HBc in living cells, HBc was tagged with green fluorescent protein (GFP). Being assembly-incompetent, the GFP-fusion protein was distributed equally throughout the cell. Mutational inactivation of known serine-phosphorylation sites within the C-terminal region led to predominantly intranuclear localization. Phosphorylation of these targets, presumably by an SR domain protein kinase, resulted in a predominantly cytoplasmic localization, which suggests active cytoplasmic export or retention. The phosphoserine itself, and not its negative charge, appears essential for the underlying mechanism. In addition, the arginine-rich, protamine-like domain surrounding these phosphorylation sites does not function as the dominant nuclear-localization signal, as had been assumed previously, because neither deleting nor altering these sequences led to a change in intracellular HBc subunit distribution. Restoring the capability of the fusion protein to form capsids by co-assembly with assembly-competent, sterically uncompromised HBc subunits provided a second assay that gave insight into the effects resulting from capsid formation. Assembly was found to be the dominant factor in the cytoplasmic retention of the GFP-HBc fusion protein. Furthermore, the stability of these empty capsids was influenced by the cell-cycle inhibitor nocodazole. Thus, the intracellular distribution of HBc is dominated by cytoplasmic assembly, which is supported by the active nuclear export of HBc subunits, and modulated during the cell cycle by the instability of capsids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741067     DOI: 10.1099/vir.0.013698-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Mechanisms and Effects on HBV Replication of the Interaction between HBV Core Protein and Cellular Filamin B.

Authors:  Yilin Li; Yishuang Sun; Fuyun Sun; Rong Hua; Chenlin Li; Lang Chen; Deyin Guo; Jingfang Mu
Journal:  Virol Sin       Date:  2018-03-28       Impact factor: 4.327

2.  Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.

Authors:  Guoyi Wu; Bo Liu; Yingjun Zhang; Jing Li; Alla Arzumanyan; Marcia M Clayton; Raymond F Schinazi; Zhaohe Wang; Siegfried Goldmann; Qingyun Ren; Faxhou Zhang; Mark A Feitelson
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

3.  Nuclear export and import of human hepatitis B virus capsid protein and particles.

Authors:  Hung-Cheng Li; Er-Yi Huang; Pei-Yi Su; Szu-Yao Wu; Ching-Chun Yang; Young-Sun Lin; Wen-Chang Chang; Chiaho Shih
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

4.  Cyclin-dependent kinase 2 phosphorylates s/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids.

Authors:  Laurie Ludgate; Xiaojun Ning; David H Nguyen; Christina Adams; Laura Mentzer; Jianming Hu
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

5.  Phosphorylation state-dependent interactions of hepadnavirus core protein with host factors.

Authors:  Laurie Ludgate; Christina Adams; Jianming Hu
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

6.  Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles.

Authors:  Izzat Fahimuddin Bin Mohamed Suffian; Yuya Nishimura; Kenta Morita; Sachiko Nakamura-Tsuruta; Khuloud T Al-Jamal; Jun Ishii; Chiaki Ogino; Akihiko Kondo
Journal:  J Nanobiotechnology       Date:  2015-02-13       Impact factor: 10.435

7.  Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.

Authors:  Izzat Fahimuddin Bin Mohamed Suffian; Julie Tzu-Wen Wang; Naomi O Hodgins; Rebecca Klippstein; Mitla Garcia-Maya; Paul Brown; Yuya Nishimura; Hamed Heidari; Sara Bals; Jane K Sosabowski; Chiaki Ogino; Akihiko Kondo; Khuloud T Al-Jamal
Journal:  Biomaterials       Date:  2016-12-14       Impact factor: 12.479

8.  Design and Synthesis of Hepatitis B Virus (HBV) Capsid Assembly Modulators and Evaluation of Their Activity in Mammalian Cell Model.

Authors:  Karina Spunde; Brigita Vigante; Unda Nelda Dubova; Anda Sipola; Irena Timofejeva; Anna Zajakina; Juris Jansons; Aiva Plotniece; Karlis Pajuste; Arkadij Sobolev; Ruslan Muhamadejev; Kristaps Jaudzems; Gunars Duburs; Tatjana Kozlovska
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-22

9.  A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

Authors:  Irina Sominskaya; Dace Skrastina; Ivars Petrovskis; Andris Dishlers; Ieva Berza; Maria Mihailova; Juris Jansons; Inara Akopjana; Irina Stahovska; Dzidra Dreilina; Velta Ose; Paul Pumpens
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.